LPCAT Antibodies

Santa Cruz Biotechnology features a diverse variety of LPCAT Antibodies for advanced research in lipid metabolism and cellular signaling. Monoclonal LPCAT Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LPCAT, or lysophosphatidylcholine acyltransferase, plays a crucial role in the synthesis of phospholipids, which are essential components of cell membranes. By catalyzing the acylation of lysophosphatidylcholine, LPCAT contributes to membrane integrity and cellular signaling pathways, impacting processes such as inflammation and cell proliferation. Understanding LPCAT function is vital for elucidating its role in various diseases, including cancer and metabolic disorders. Research has shown that LPCAT expression levels can vary significantly in different tissue types and disease states, making it an important target for therapeutic development. Investigating LPCAT activity can provide critical information about membrane dynamics and cellular responses to various stimuli. LPCAT research continues to reveal new insights into cellular metabolism and disease progression. Santa Cruz Biotechnology monoclonal LPCAT antibodies enable researchers worldwide to advance scientific understanding of lipid metabolism and its impact on human health.